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The large-conductance voltage and calcium-sensitive BK
channel is important in many electrically active cells. Its
unique sensitivity to both intracellular calcium levels and
membrane potential makes it a key regulator of intracellular
calcium, a critical second messenger in cells. The BK channel
is expressed ubiquitously in the body and has particularly
significant roles in the neuronal and smooth muscle cells.
More recently, the importance of BK channel in the
pathophysiology of hypertension has been demonstrated.
In this review, we will focus on function, regulation, and
clinical significance of the BK channel. We will also specifically
concentrate on one of its b-subunits, b1, which is important
in vascular and renal physiology.
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The BK channel (Maxi-K, Slo1, KCa1.1, Big Potassium) is a
large-conductance potassium channel. It is unique among
potassium channels in that it is activated, or gated, both by
membrane depolarization and intracellular calcium (Ca2þ ),
making it particularly suited for intracellular Ca2þ regula-
tion.1 Activation of the channel leads to pore opening and
outward potassium (Kþ ) flux, which shifts the membrane to
more negative potentials. This membrane hyperpolarization
reduces activity of L-type Ca2þ channel (LTCC) and other
high-voltage-gated Ca2þ channels. Thus, the BK channel
can be viewed as a ‘thermostat’, regulating the intracellular
Ca2þ concentration. The ability of BK channel to sense
both membrane depolarization and intracellular Ca2þ allows
it to integrate these signals to fine-tune the electrical activity
of the cell.
In humans, alterations in the BK channel are known to
be important to the pathophysiology of hypertension,2–6
epilepsy,7–10 cancer,11–15 and asthma.16 This review will focus
on the function and regulation of the BK channel expressed
on the plasmalemma of cells with a focus on the BK channel
auxiliary protein, the b1 subunit. We will also discuss clinical
studies of the channel with emphasis on blood pressure and
kidney function.
STRUCTURE–FUNCTION
BK a-subunit
A functional BK channel is composed of a tetramer of
a-subunits that form the pore of the channel. The existence
of the channel was first detected in the Drosophila slowpoke
mutant in the early 1980s.17 The a-subunit, encoded by the
KCNMA1/Slo1 gene, was then cloned from Drosophila and
mice in the early 1990s.18–20 The BK channel is expressed in a
wide variety of tissues.21 It is most abundant in the brain and
smooth muscle-containing organs, but has also been detected
in a wide variety of other tissue types, including the
reproductive organs (ovary, testes), pancreas, and adrenal
glands, but, notably, not in cardiac (ventricular) myocyte
plasma membranes.
The ubiquitous expression of the channel is reflected by
the multiple abnormalities observed in mice with targeted
deletion of the BK channel gene.22–25 These mice have
cerebellar dysfunction in the form of impaired motor
coordination, abnormal locomotion, and abnormal eye blink
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reflex that is due, in part, to reduction of activity of cerebellar
Purkinje cells.22,25 They also develop systemic hypertension
caused by altered vascular tone, as determined by vessel
diameter measurements of pressurized arteries, and hyper-
aldosteronism, perhaps resulting from loss of BK channel in
the adrenal gland or impaired renal potassium handling.24,26
BK a-subunit null mice also have increased bladder contrac-
tions and urinary frequency, confirming the importance of BK
channel in non-vascular smooth muscle tissues.25,27,28 Inter-
estingly, a smooth muscle-specific inducible BK deletion model
produces a more severe overactive bladder phenotype.
Compensatory mechanisms such as decreased LTCC current
density, increased protein kinase A (PKA) expression, and
blunted response to b-adrenergic stimulation may attenuate
the effects of constitutive BK deletion.29
The BK channel shares homology with all voltage-gated
Kþ channels with six transmembrane (TM) helices, S1–S6,
and a pore helix (Figure 1a). The S1–S4 helices are arranged
in a bundle that forms the voltage-sensing unit of the
channel and the S5–S6 and pore helices form the pore and the
Kþ selectivity filter. The BK channel is unique among
voltage-gated Kþ channels, in that it contains an additional
S0 helix N-terminal to S1.30 On the basis of the crystal
structures of the mammalian voltage-gated Kþ channel
KV1.2 and a chimera of KV1.2/KV2.1,
31,32 as well as disulfide
crosslinking of the extracellular flanks of the TM helices,33,34
we have determined the S0 TM helix closest to S3–S4,
between two neighboring a-subunits (Figure 1c). The N-
terminal segment crosses over the S3–S4 extracellular loop,
forming an endogenous disulfide between a Cys14 in the
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Figure 1 | The BK a- and b-subunits. Scheme representing the threading of BK a- (a) and b- (b) subunits through the membrane.
(c) Proposed arrangement of a-subunit transmembrane helices at the level of the membrane, top down view. The S1–S6 helices are
based on the KV1.2/KV2.1 structure.
31 (Adapted from Liu et al.33).
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N-terminal segment and Cys141 in the S1–S2 extracellular
loop. The S0 TM helix and N-terminal segment extracellular
to the S0 domain are required for the b1 subunit to modulate
the channel.30,35–37
Similar to other voltage-gated Kþ channels, the BK channel
contains charged arginines (Arg) in the S4 domain, which
collectively contribute to the gating charge (qgating). However,
only one of these Arg (Arg213) together with positively charged
residues in S2 (Asp153, Arg167) and S3 (Asp186) are
potentially voltage sensing.38,39 Compared with other voltage-
gated Kþ channels, the BK channel V50’s for gating charge
movement (gating current) and for channel opening are shifted
to much more positive voltages. Although the BK channel has a
smaller gating charge, the electrostatic energy required for
activating the voltage sensors is greater for the BK channel than
for other voltage-gated Kþ channels.38,40,41
The C-terminal tail confers the Ca2þ -sensing ability of the
BK channel, which is thought to involve two Ca2þ -sensing
domains that regulate the conductance of Kþ (RCK), RCK1,
and RCK2. The presence of RCK domains in the BK channel
was inferred from structural data of prokaryotic Ca2þ -gated
potassium channels containing RCK domains.42,43 The
second RCK domain contains a Ca2þ bowl domain and
the importance to Ca2þ sensing has been confirmed.43–47
The recently solved crystal structure of the BK channel C
terminus shows that the octamer of RCK domains in a
complete BK channel forms an intracellular Ca2þ -gating
ring.48 Opening of the Ca2þ -gating ring is thought to
couple to channel opening by tugging on the pore through
a spring-like S6-RCK1 linker in response to Ca2þ .49
Correlation of this structure to mutational studies suggests
that the C terminus may also have the ability to influence
channel opening by modulating the voltage sensor, in
addition to affecting the pore directly.48,50
Although membrane potential and Ca2þ levels are the
primary determinants of BK channel activation, other factors
also influence channel opening. The BK channel Ca2þ
sensors have high specificity for Ca2þ over other divalent
cations.51 However, magnesium (Mg2þ ) also affects channel
gating.52 Although it is ineffective at opening the BK channel,
Mg2þ enhances activation of opened channels through a
distinct binding site involving the voltage sensor and RCK1
domain.44,50,53,54 Channel gating can also be affected by the
redox state of the channel.55 The effects of redox modifica-
tions on the BK channel are complex, because of amino acid-
specific effects of oxidation and perhaps differential
b-subunit expression.56–60 Preferential oxidation of methio-
nines generally enhances activation of the channel, whereas
oxidation of cysteines generally inhibits the channel.57,58
Redox state of the channel also appears to influence BK
channel interactions with other proteins, such as heme.61
BK b-SUBUNITS
The BK channel associates with modulatory b-subunits.
These proteins are expressed in a cell-specific manner with
each having unique regulatory effects on the channel. This
fine-tuning of the channel accounts in part for the func-
tional diversity of the BK channel. There are four distinct
b-subunits, b1–4 (KCNMB1, KCNMB2, KCNMB3, and
KCNMB4) (Table 1). The b1 subunit is expressed in smooth
muscle and kidney, among other tissues.62–65 The b4 subunit is
primarily expressed in neuronal tissue.21,66 Deletion of the BK
b4 gene (KCNMB4) in mice leads to temporal lobe epilepsy
and increased tolerance to alcohol, suggesting a role of the
b4 subunit in alcohol sensitivity.67,68 The b2 subunit is
expressed most abundantly in the brain as well as the pancreas
and uterus.21,47,69 The b3 subunit is the least studied of the
b-subunits. It is expressed in a wide variety of tissues, including
brain.7,21,66,70 A nonsense mutation leading to a truncation of
the C-terminal end of the b3 subunits in humans has been
implicated in idiopathic generalized epilepsy.10
BK channel b-subunits consist of two TM domains with
intracellular N and C-termini and a long extracellular loop
(Figure 1b). The b-subunits are believed to co-assemble in a
Table 1 | b-Subunit waveforms and characteristics
a a+b1 a+b2 a+b3a a+b4
Most abundant expression Smooth muscle Brain
Pancreas
Ovary
Brain
Pancreas
Spleen
Liver
Brain
Testes
Adrenal gland
Effects on BK channel m Apparent Ca sensitivity
m Surface trafficking
Activating
Rapid inactivation
Perhaps activating
Rapid inactivation
Outward rectification
Inhibits channel
at low calcium
Promotes channel
opening at high
calcium
Physiologic function Blood pressure
Glomerular filtration
Potassium metabolism
Bladder function
Unknown Brain function Brain function
Alcohol tolerance
Shown above are BK channel waveforms and characteristics.
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1:1 stoichiometry with the a-subunit.71 Disulfide cross-
linking studies have shown that the extracellular flank of the
first TM helix (TM1) is localized near the S1 and S2 helices of
a and the second TM helix (TM2) is localized near the S0
domain of a (Figure 1c).34,72 This places the extracellular
ends of the b-TM helices within the crevice formed by
neighboring voltage-sensing bundles of the a-subunit.33 The
b-subunit extracellular loop can confer variable resistance
to toxins (for example, iberiotoxin) and the intracellular
N- and C-termini can confer a variety of electrophysiologic
effects.56,69,73–77
The b1 subunit was the first BK b-subunit to be cloned
and is primarily expressed in smooth muscle cells.62,65,78,79
The b1 subunit alters the gating kinetics to favor a more open
state and, to a lesser degree, increases Ca2þ affinity.41,80 The
result is a shift of channel activation to more negative
membrane potentials. Physiologically, the b1 subunit enhan-
ces the coupling of ryanodine receptor-mediated Ca2þ
sparks to BK channel-mediated spontaneous transient
outward currents. An increased frequency and amplitude of
spontaneous transient outward currents lead to hyperpolar-
ization of smooth muscle cells, and subsequent reduction of
Ca2þ influx and relaxation. b1 coexpression with a also
increases surface trafficking of the a-subunit.81
Deletion of the b1 subunit in mice leads to increased
arterial tone and elevated systemic blood pressure.63,82 BK
channels from smooth muscle cells isolated from these mice
were less responsive to Ca2þ and had abnormal coupling of
Ca2þ sparks to spontaneous transient outward currents.
Subsequent studies have also found that loss of the b1
subunit leads to impaired flow-stimulated kaliuresis resulting
in hyperaldosteronism.64,83 Smooth muscle dysfunction also
manifests in the bladder with decreased contraction ampli-
tude and contraction frequency.84
Alternative splicing of the a-subunit
The BK channel is subject to extensive alternative splicing,
which can have significant consequences on the function of
the channel.85–89 One variant in particular, the STREX (stress
axis-regulated exon) variant, has striking effects on channel
function.88 This splice variant is formed by the inclusion of
an exon encoding a 59 amino acid addition in the C-terminal
tail of the channel. Exposure to androgens in adrenal
chromaffin cells and progesterone or estrogen receptor
antagonists in myometrial cells stimulates inclusion of the
STREX exon.90,91 Conversely, glucocorticoids cause exclusion
of the STREX exon in adrenal chromaffin cells.91
The STREX variant is a more active channel than the
channels lacking the exon (ZERO variant), opening at more
negative potentials.88 Regulation by kinases is also affected, as
PKA activates BK channels in the absence of the STREX exon,
but inhibits channels containing the STREX exon by
phosphorylating an exon-specific PKA consensus site.92 The
inhibitory effects of PKA phosphorylation on STREX-contain-
ing channels are blocked by glucocorticoids.93 In addition, the
STREX exon alters the effects conferred by the b4 subunit.94
Phosphorylation
Phosphorylation is the final common pathway of many
cellular signaling pathways. Adrenergic, nitric oxide, and
renin-angiotensin-aldosterone systems all have important
roles in biological processes and can exert their effects
through phosphorylation. For all of these pathways, the BK
channel represents an important phosphorylation target.95,96
Through b2-adrenergic receptor stimulation, isoprotere-
nol activates the BK channel ZERO splice variant, both
through direct stimulation by G-proteins and G-protein-
coupled activation of PKA.97 Phosphorylation of all four
subunits of the tetramer are required for the stimulatory
effect on the ZERO splice variant, whereas phosphorylation
of only one subunit of the tetramer at the STREX-specific
PKA site is required to inhibit the channel.98 PKA
phosphorylation requires a macromolecular signaling com-
plex between BK channel, the b2-adrenergic receptor, and
AKAP79/150.99 We also showed that BK channels and LTCC
form a macromolecular complex through dimerization of the
b2-adrenergic receptor.99 The PKA catalytic subunit was
shown to associate with the BK channel C terminus through
leucine zipper interactions,99,100 similar to the leucine zipper-
mediated interactions found for ryanodine receptor,101
KCNQ1-KCNE1,102 and LTCC.103
The nitric oxide/cyclic guanosine monophosphate
(cGMP) pathway activates the BK channel through protein
kinase G.104–106 It has also been suggested that protein kinase
G is the primary pathway of BK channel stimulation by both
cAMP and cGMP.107 Dopamine receptor-mediated stimula-
tion of BK channel may occur through protein kinase G, and
has been shown to mediate relaxation in coronary and
perhaps renal arteries.108
The effects of protein kinase C on the BK channel are less
clear, likely reflecting the diversity of protein kinase C
isoforms and function in different tissues. Experiments in
different cell types have shown both inhibitory and
stimulatory effects on BK.109–115 In addition, it has been
suggested that protein kinase C phosphorylation has two
roles, one mediating direct inhibition of the channel, and
another as a switch to influence the effects of PKA and
protein kinase G phosphorylation on the channel.116,117
BK CHANNEL IN HYPERTENSION
Smooth muscle cells
BK channel function is perhaps best characterized in smooth
muscle cells, which are the primary determinants of blood
vessel contractility. Endothelial BK channels may also
influence vascular tone by altering endothelial function, but
the characterization of BK channel in these cells is still in the
nascent stages.118 A variety of Kþ channels in addition to BK
channel are expressed in smooth muscle cells, including other
voltage-gated Kþ channels, inward rectifying channels, and
ATP-sensitive Kþ channels. However, BK channel is unique
in its role in Ca2þ handling and myocyte contraction due to
its unique sensitivity to both Ca2þ and voltage as well as its
large conductance.
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In arterial smooth muscle cells, membrane depolarization
triggers opening of the LTCC leading to Ca2þ influx into
the cell, which along with sarcoplasmic reticulum Ca2þ
release, increases global cytoplasmic Ca2þ , and promotes
myocyte contraction (Figure 2).119 At least two channels in
the sarcoplasmic reticulum participate in Ca2þ release, the
ryanodine receptor and the inositol triphosphate receptor.
The inositol triphosphate receptor is more abundant than
ryanodine receptor in smooth muscle cells and responds
primarily to inositol triphosphate, generated from activation
of G-protein-coupled receptors and phospholipase C, as
well as cytoplasmic Ca2þ and perhaps direct metabotropic
stimulation from the LTCC.120,121 The ryanodine receptor
participates in Ca2þ -induced Ca2þ release and is affected by
both cytoplasmic and luminal sarcoplasmic reticulum
Ca2þ .122,123 Ca2þ flux through ryanodine receptor is not
equally distributed through the cytoplasm of the cell, with
highest concentrations found within 20 nm of the chan-
nel.124,125 Thus, ryanodine receptor opening rapidly generates
a large, local increase in Ca2þ levels, a phenomenon known
as a Ca2þ spark.126 In vascular smooth muscle cells, opening
of the ryanodine receptor leads to Ca2þ -driven activation of
the BK channel and resultant outward Kþ flux, known as
spontaneous transient outward currents.127,128 In this way,
the BK channel acts similar to an endogenous Ca2þ channel
blocker counteracting the effects of the LTCC. This interplay
between the BK channel, ryanodine receptor, and LTCC
forms a balance that can favor contraction or relaxation
depending on regulation of the system.
The importance of the BK channel in vascular smooth
muscle cell function was clearly demonstrated in arterial tone
studies in the a- and b1-null mice. Compared with wild-type
mice, cerebral arteries from b1-null mice had increased
constriction, measured by vessel diameter in response to
pressure.63 This difference was eliminated by applying the
BK-specific blocker iberiotoxin, which had very little effect
on the b1-null mice arteries. Similarly, BK a-null mice had
increased tibial artery constriction measured by luminal
diameter analysis compared with wild-type mice.24 The
investigators also found that the BK a-null mice had
impaired response to cGMP-mediated, but not adenosine-
mediated, vasorelaxation indicating that the BK channel is an
important effector of the cGMP pathway.
The b1 subunit expression is affected in disease models.
b1 expression is decreased in vascular smooth muscle cells from
hypertensive, diabetic, and hypoxic rodent models, likely
accounting, in part, for the observed abnormalities in vascular
reactivity observed in these diseases.129–132 Conversely, upregu-
lation of b1 and enhanced coupling of Ca2þ sparks to BK
channel activation was found in a rodent model of hemorrhagic
shock, suggesting that BK channels may also contribute to
reduced vascular tone complicating hemorrhagic shock.133
Renin-angiotensin-aldosterone system
The BK channel and renin-angiotensin-aldosterone system
are functionally intertwined. Angiotensin II has complex
effects on the BK channel in different tissues.134,135 b1
subunit expression is reduced by angiotensin II through the
calcineurin/NFATc3 pathway.136 Administration of angioten-
sin II to wild-type mice causes a decrease in cerebral
arterial b1 subunit mRNA transcription and an increase in
blood pressure. These changes are not seen in the mice with
deletion of the NFATc3 gene. In a streptozocin-induced
diabetic rat model, the inhibitory effect of angiotensin II on
BK channel in coronary arteries is enhanced, because of the
increased caveolar targeting of the channel.137 The renin-
angiotensin-aldosterone system also regulates a-subunit
expression. Mice with constitutively overexpressed aldoster-
one synthase downregulate BK channel mRNA transcription
and protein expression in smooth muscle cells.138 This
translates into impaired relaxation of vascular rings on wire
myograph.
The BK channel a-subunit is expressed in the zona
glomerulosa of the adrenal gland, and disruption of the BK
channel in the adrenal gland is postulated to generate
increased aldosterone levels accounting in part for the
hypertension observed in a-subunit null mice.24 This study
found increased myogenic tone in the a-null mice, suggesting
that vascular dysfunction from impaired BK channel function
in vascular smooth muscle cells could also contribute to the
observed hypertension. Grimm et al.83 investigated whether
hyperaldosteronism was also present in the b1-null mouse.
b1-null mice have impaired flow-stimulated Kþ secretion,
leading to compensatory hyperaldosteronism and subsequent
hypertension. These mice were treated with the mineralo-
corticoid receptor antagonist eplerenone, which reduced
blood pressure by 70%. The authors concluded that the
elevated blood pressure in the b1-null mouse is primarily due
to hyperaldosteronism caused by defective Kþ handling in
the distal nephron.
Human hypertension studies
Single-nucleotide polymorphisms of the b1 subunit have
been correlated with both heart rate variation and baroreflex
response, suggesting it is important in the physiology of
blood pressure.139 The most well-studied polymorphism in
humans is the b1 Glu65Lys variant.2 This Lys-substitution
polymorphism of the b1 loop resulted in a small but
significant activating shift of the channel’s conductance–
voltage relationship compared with Glu65 in vitro. The Lys
variant also conferred protection from diastolic hypertension
in a subset of strictly normotensive and strictly hypertensive
patients in a population-based genetic study of a Spanish
cohort (REGICOR study). A separate analysis of this cohort
investigated the effect of age and sex on these protective
effects.3 This study found that the correlation between the
Glu65Lys variant and protection from hypertension was
more robust in older women, with additional association of
decreased risk of the combined end point of myocardial
infarction or stroke. Subsequently, an investigation of the
Inter99 cohort also found Glu65Lys-associated protection
from hypertension.5 This was a retrospective case–control
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analysis of Danish patients, which found a correlation
of Glu65Lys carrier status with lower systolic, diastolic,
and mean arterial blood pressure. A reduction in risk of
hypertension was not found in a separate study of
Japanese patients.140 This study was designed to confirm
the effects of three previously published genetic variants
associated with significant effects on hypertension, one of
which was the Glu65Lys variant of BK b1. This study did not
find any correlation of the variant with protection from
hypertension. Authors suggested that this might be due to a
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Figure 2 |A model for the role of BK channel in Ca2þ handling in vascular smooth muscle. (a) Under conditions supporting
vasoconstriction, global Ca2þ increase and sarcoplasmic reticulum (SR) calcium release driven by L-type Ca2þ channel (LTCC) and the
inositol triphosphate (IP3)/Ca2þ /metabotropic activated release of the IP3 receptor (IP3R), respectively, promote cell contraction. (b) Under
conditions supporting an intermediate level of vessel constriction, LTCC activation is balanced by BK channel activity. Global Ca2þ levels are
decreased by Naþ–Ca2þ exchanger (NCX) extrusion and Ca2þ–ATPase (SERCA) loading into the SR. (c) Under conditions favoring
vasodilation, periplasmalemmal RyR Ca2þ release is stimulated by SR luminal Ca2þ levels, leading to a localized Ca2þ spark that activates
the BK channel. This leads to hyperpolarization of the membrane and inhibition of LTCC activity.
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modest benefit of the variant over Glu65 or ethnicity-specific
differences.
The influence of BK channel genotype on sensitivity to
antihypertensive medications has also been investigated. One
such study involved two cohorts (Heart Score and Framing-
ham) and correlated Glu65Lys carrier status with blood
pressure.141 This study found a significant association of
Glu56Lys carrier status with lower systolic and diastolic blood
pressure only in the setting of antihypertensive treatment. A
pooled analysis of the two populations suggested that this
difference was found primarily in patients treated with
b-blockers. Another study evaluated the effect of b1 variants
on response to the Ca2þ channel blocker verapamil.142 The
cohort was derived from patients in the INVEST study, a
prospective randomized trial comparing the effect of sustained
release verapamil to atenolol on cardiovascular outcomes.143
The analysis found that in patients treated with verapamil,
those carrying a Val110Leu variant were less likely to reach the
primary outcome of death, myocardial infarction, or stroke
than patients homozygous for the Val110 allele. A significant
difference was not observed in the arm that was treated with
atenolol. These investigators also did not find a significant
difference in the primary end point between Glu65Lys carriers
and those with the Glu65 genotype, but did find that Glu65Lys
carriers treated with verapamil reached target blood pressure
faster and required fewer medications.
BK a-subunit variations are also important in hyper-
tension. Another analysis of the Spanish REGICOR
study investigated the BK a-subunit C864T variant and
the intronic IVS17þ 37T4C (substitution from T to C
of the 37th base pair upstream of exon 17) variant in
relation to hypertension.4 They found that both of
these genotypes independently correlated with increased
risk of hypertension and presence of both variants
increased risk for myocardial infarction. It is unclear how
the intronic variation alters the channel. The investigators
explored the possibility of alternative splicing, but no
evidence of this was found. The authors suggest that this
change may alter the mRNA processing or associate with a
distinct and physiologically important alteration through
linkage disequilibrium. These findings further established
the BK channel as an important factor in hypertension
and cardiovascular risk.
RENAL FUNCTION AND Kþ HANDLING
BK channel in the kidney
The BK channel a-subunit has been found in nearly every
segment of the nephron, and all b-subunit subtypes have
been found in the nephron.144–147 The role of BK channel in
the kidney is complex and requires further investigation.
Here, we will focus on the BK channel effects on Kþ
secretion and refer readers to a more comprehensive review
for further details.148
The segment in which BK channel is the most studied and
functionally elucidated is in the distal nephron. BK channel is
localized on the apical membrane of these cells along with the
Renal Outer Medullary Kþ channels (ROMK/Kir1.1/KCNJ1/
SK, not to be confused with small calcium-activated
potassium channel SK/KCa2.1-3/KCNN1-3), which underlie
baseline luminal Kþ secretion.149 It is here in the principal
cells that BK channel likely mediates flow-stimulated
kaliuresis. b1-null mice have decreased fractional excretion
of Kþ , decreased glomerular filtration rate, and increased
excretion and fractional excretion of Naþ in response
to acute volume expansion.64 As expected, studies in the
a-subunit null mouse also found that Kþ secretion was
disrupted in response to increased flow as well as high Kþ
load.26 Mice lacking the ROMK channel, a mouse model for
Type II Bartter syndrome, are initially hyperkalemic as
newborns, but later develop hypokalemia, which is in part
due to enhanced BK channel activity, perhaps in response to
high flow.150 This Kþ secretion is ablated in ROMK null
mice by administration of BK-specific iberiotoxin suggesting
that the ROMK and BK channels account for the vast
majority of Kþ secretion in the distal tubules.
The b4 subunit is also found in the nephron, where it is
expressed in the thick ascending limb, intercalated cells,
and distal convoluted tubule.144 In response to a high Kþ diet,
b4-null mice have less urinary flow, less fractional excretion of
Naþ and Kþ , and increased volume and Kþ retention with
similar aldosterone levels compared with wild-type mice.151 In
this setting, b4 null mice had larger intercalated cells, leading to
a smaller luminal diameter. Findings in this model suggest that
the b4 subunit reduces intercalated cell size and increases
intraluminal volume in the distal tubule to accommodate
higher flow rates in response to high Kþ loads.
The mechanism of how BK channel is activated in the
kidney is still being elucidated. Detection of luminal
mechanical stress on the apical membrane represents a
potential mechanism for detecting flow. A candidate for
mediation of this sensitivity in the cortical collecting duct is
the TRPV4 channel (Figure 3).152 TRPV4 is a nonselective
cation channel with Ca2þ permeability. It can be activated by
a variety of stimuli, including mechanical stress. In other
tissues, TRPV4 can couple Ca2þ entry with the BK channel
to form Ca2þ -signaling complexes conferring functional
mechanosensitivity to BK.153,154 Furthermore, disruption of
TRPV4 in mice leads to impaired flow-stimulated Kþ
excretion.155 While this is an attractive model, a role for
the coupling of BK channel and TRPV4 in the process of
flow-stimulated Kþ secretion has not been proven. There
have been conflicting reports on whether TRPV4 exists on the
apical membrane of the cortical collecting duct, but the
majority of findings now support the existence of apical
expression.152,156–158
BK channel in distal colonic Kþ secretion
BK is also important in other avenues of Kþ regulation. The
BK channel can be found on the apical membrane of distal
colonic epithelial cells, and experiments on BK channel
a-subunit null mice suggest that BK channels underlie Kþ
secretion in the distal colon.147,159 In rodent models, this
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excretion is increased by aldosterone and epinephrine and
may be an important source of Kþ loss in diarrhea.160–162
In humans, studies suggest that BK channel-mediated distal
colonic Kþ secretion may be an important source of Kþ loss
under certain circumstances. In a study of colonic biopsies,
ulcerative colitis patients demonstrated increased expression of
BK channel in the colonic crypts when compared with normal
controls, suggesting that upregulation of BK channel may be an
important source of Kþ loss in ulcerative colitis-associated
diarrhea.163 In end-stage renal disease (ESRD), BK channel may
be a significant source of Kþ excretion. In a study comparing
ESRD to normal patients, ESRD patients were found to have
increased immunostaining of BK channel in colonocytes and
crypt cells and threefold higher rectal Kþ secretion than
healthy controls.164 Overexpression of apical BK channels in the
colon may also be responsible, in part, for some cases of
secretory Kþ loss in hemorrhagic shock.165 A case report of a
chronic secretory diarrhea in an ESRD patient after an episode
of hemorrhagic shock found dramatically increased BK channel
staining in the colonocytes and crypt cells in comparison
with those of ESRD patients. These results suggest that distal
colonic secretion of Kþ can be significant with upregulated BK
channel expression. Elucidation of the mechanisms promoting
this upregulation requires further investigation.
CLINICAL TRIALS OF BK CHANNEL MODIFIERS
The road of BK channel modulators to the realm of clinical
medicine has been paved with disappointment. The first and
most clinically well-studied BK modulator was BMS-204352,
developed by Bristol Myers Squibb. BMS-204352 was
found to have neuroprotective effects in an animal model
of cerebral infarct.166 In rats, cerebral vessels were occluded
and BMS-204352 infused 2 h after onset of infarct signifi-
cantly reduced infarct size. This compound was brought to
phase III trial, where the trial did not find a beneficial
effect in comparison with placebo.167 Two other compounds,
NS8 and TA1702, reached phase II trials, but were likely
abandoned by the sponsoring companies presumably due to
lack of benefit in the trial.168 A phase I trial involving gene
transfer of the BK channel to treat erectile dysfunction and
overactive bladder was safe, but further data have not
been published.169 Other studies have found BK channel to
be incidentally involved in the effects of therapeutic agents.
An uncontrolled study of the cGMP-specific phosphodiester-
ase inhibitor sildenafil in patients with New York Heart
Association Class II and III pulmonary arterial hypertension
suggested that the BK channel was the primary downstream
effector responsible for the vasodilatory effects in the
pulmonary arteries of these patients.170 The benefit of
sildenafil in patients with pulmonary hypertension has been
validated.171
CONCLUSIONS
The BK channel has critical and unique roles in Ca2þ
signaling. In smooth muscle cell, the channel is centrally
involved in setting the sarcolemmal membrane potential,
which controls the activity of voltage-dependent Ca2þ
channels, and hence contractility. In the nephron, the
channel is an important regulator of Kþ handling. The b1
subunit, which is primarily expressed in smooth muscle cells,
has a role in blood pressure regulation. Its importance is
being increasingly recognized in the setting of hypertension
and hypertensive renal disease. Clinical studies have con-
firmed this significance, but the understanding of how to
utilize this knowledge is still in its nascent stage. Future
research will focus on studying channel regulation and
alterations in disease states and effective manipulation
of the channel.
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Figure 3 |Proposed mechanism for flow-stimulated kaliuresis in the apical membrane of a cortical collecting duct principal cell.
Basal secretion of Kþ is predominantly mediated by Renal Outer Medullary Kþ channel (ROMK), which is expressed more abundantly than
the BK channel. Flow-mediated mechanical stress on the apical membrane leads to TRPV4 activation, which results in more positive
membrane potentials and Ca2þ influx, thereby activating the BK channel.
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